Form 4: OS Therapies Inc. Director Sells Shares in Open Market Transaction

A director of OS Therapies Inc., Shalom Auerbach, sold 16,720 shares of common stock at an average price of $6.735 per share.

Summary

• Shalom Auerbach, a director of OS Therapies Inc., sold 16,720 shares of common stock.
• The shares were sold on January 15, 2025, at a weighted average price of $6.735 per share.
• The sales occurred in multiple transactions with prices ranging from $6.618 to $6.80 per share.
• Following the transaction, Mr. Auerbach indirectly beneficially owns 2,531,211 shares through Einodmil LLC, where he serves as Principal.
• Mr. Auerbach also directly owns 23,371 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of a share sale by a director, with no indication of positive or negative sentiment.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders when they trade company stock. It provides transparency into the trading activities of company directors and officers.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The sale by Mr. Auerbach is similar to other insider transactions reported by directors and officers of publicly listed companies.
• The price range of $6.618 to $6.80 per share is within the typical range for open market transactions.

Stakeholder Impact

• The share sale may have a minor impact on the stock price, but it is unlikely to be significant given the relatively small volume of shares sold compared to the total shares outstanding.
• The transaction provides transparency to shareholders regarding insider trading activity.

Key Dates

Keywords

OS Therapies Inc, OSTX, Shalom Auerbach, insider trading, share sale, Form 4, director, Einodmil LLC